Safety and Efficacy Study for DC Vaccine in Recurrent or Progressive High-grade Gliomas
Safety and Efficacy Study for DC Vaccine in Recurrent or Progressive High-grade Gliomas
Active, not recruiting · NCT06253234 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study for DC Vaccine in Recurrent or Progressive High-grade Gliomas | WHO Grade III Gliomas; WHO Grade IV Gliomas | Active, not recruiting | Phase 1 | 2026-09-28 | NCT06253234 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Tiantan Hospital | 307 |
| ZhongSheng BioTech Inc. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Tiantan Hospital, Capital Medical University | Beijing | China | 1 |